| アブストラクト | Importance: Despite considerable improvements in heart failure care, mortality rates among patients in high-income countries have changed little since the early 2000s. Understanding the reasons underlying these trends may provide valuable clues for developing more targeted therapies and public health strategies. Objective: To investigate mortality rates following a new diagnosis of heart failure and examine changes over time and by cause of death and important patient features. Design, Setting, and Participants: This population-based retrospective cohort study analyzed anonymized electronic health records of individuals who received a new diagnosis of heart failure between January 2002 and December 2013 who were followed up until December 2014 from the Clinical Practice Research Datalink, which links information from primary care, secondary care, and the national death registry from a subset of the UK population. The data were analyzed from January 2018 to February 2019. Main Outcomes and Measures: All-cause and cause-specific mortality rates at 1 year following diagnosis. Poisson regression models were used to calculate rate ratios (RRs) and 95% confidence intervals comparing 2013 with 2002, adjusting for age, sex, region, socioeconomic status, and 17 major comorbidities. Results: Of 86833 participants, 42581 (49%) were women, 51215 (88%) were white, and the mean (SD) age was 76.6 (12.6) years. While all-cause mortality rates declined only modestly over time (RR comparing 2013 with 2002, 0.94; 95% CI, 0.88-1.00), underlying patterns presented explicit trends. A decline in cardiovascular mortality (RR, 0.73; 95% CI, 0.67-0.80) was offset by an increase in noncardiovascular deaths (RR, 1.22; 95% CI, 1.11-1.33). Subgroup analyses further showed that overall mortality rates declined among patients younger than 80 years (RR, 0.79; 95% CI, 0.71-0.88) but not among those older than 80 years (RR, 0.97; 95% CI, 0.90-1.06). After cardiovascular causes (898 [43%]), the major causes of death in 2013 were neoplasms (311 [15%]), respiratory conditions (243 [12%]), and infections (13%), the latter 2 explaining most of the observed increase in noncardiovascular mortality. Conclusions and Relevance: Among patients with a new heart failure diagnosis, considerable progress has been achieved in reducing mortality in young and middle-aged patients and cardiovascular mortality across all age groups. Improvements to overall mortality are hindered by high and increasing rates of noncardiovascular events. These findings challenge current research priorities and management strategies and call for a greater emphasis on associated comorbidities. Specifically, infection prevention presents as a major opportunity to improve prognosis. |
|---|
| ジャーナル名 | JAMA cardiology |
|---|
| Pubmed追加日 | 2019/9/4 |
|---|
| 投稿者 | Conrad, Nathalie; Judge, Andrew; Canoy, Dexter; Tran, Jenny; Pinho-Gomes, Ana-Catarina; Millett, Elizabeth R C; Salimi-Khorshidi, Gholamreza; Cleland, John G; McMurray, John J V; Rahimi, Kazem |
|---|
| 組織名 | The George Institute for Global Health, University of Oxford, Oxford, England.;Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,;University of Oxford, Nuffield Orthopaedic Centre, Oxford, England.;Bristol National Institute for Health Research Biomedical Research Centre,;Musculoskeletal Research Unit, University of Bristol, Southmead Hospital,;Bristol, England.;Medical Research Council Lifecourse Epidemiology Unit, University of Southampton,;Southampton General Hospital, Southampton, England.;National Institute for Health Research Oxford Biomedical Research Centre,;University of Oxford, Oxford, England.;Deep Medicine, Oxford Martin School, University of Oxford, Oxford, England.;Faculty of Medicine, University of New South Wales, Sydney, Australia.;Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow and;National Heart & Lung Institute, Imperial College London, London, England.;Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow,;Scotland.;Oxford University Hospitals NHS Foundation Trust, Oxford, England. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/31479100/ |
|---|
